Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing heterocyclic carbon compound having only o – n – s,...
Reexamination Certificate
2005-01-19
2008-10-07
Lilling, Herbert J. (Department: 1657)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Preparing heterocyclic carbon compound having only o, n, s,...
C435S118000, C435S252100, C435S253200, C540S460000, C540S462000
Reexamination Certificate
active
07432088
ABSTRACT:
A process of the large-scale fermentation of a highly productive ansamitocin-producing strains. A method for isolating crude ansamitocins. A method for purifying ansamitocins.
REFERENCES:
patent: 4151042 (1979-04-01), Higashide et al.
patent: 4294757 (1981-10-01), Asai
patent: 4307016 (1981-12-01), Asai et al.
patent: 4322348 (1982-03-01), Asai et al.
patent: 4331598 (1982-05-01), Hasegawa et al.
patent: 4361650 (1982-11-01), Asai et al.
patent: 4424219 (1984-01-01), Hashimoto et al.
patent: 5208020 (1993-05-01), Chari et al.
patent: 5416064 (1995-05-01), Chari et al.
patent: 6333410 (2001-12-01), Chari et al.
patent: 6441163 (2002-08-01), Chari et al.
patent: 6573074 (2003-06-01), Fulston et al.
patent: 7192750 (2007-03-01), Chung et al.
patent: 2002/0015984 (2002-02-01), Fulston et al.
patent: 2002/0156274 (2002-10-01), Terfloth
patent: 2003/0157669 (2003-08-01), Fulston
patent: 2004/0235840 (2004-11-01), Chari et al.
patent: 2006408 (1990-06-01), None
patent: 2241418 (1974-03-01), None
patent: 27 46 253 (1978-10-01), None
patent: 26338 (1981-04-01), None
patent: 53124692 (1978-10-01), None
patent: 55029972 (1980-03-01), None
patent: 2001095943 (2000-12-01), None
patent: 2001068142 (2001-09-01), None
Yu et al “The biosynthetic gene cluster of the maytansinoid antitumor agent ansamitocin form Actinosynnema pretiosum” PNAS, Jun. 11, 2002, vol. 99, No. 12.
Abbott B. Huang, et al., “Maytansine Inhibits Nucleotide Binding at the Exchangeable Sit of Tubulin,”Biochem. Biophys. Res., (Commun. (1985), 128:(3), pp. 1239-46.
Akiyoshi Kawai, “Chemical Modification of Ansamitocins. I. Synthesis and Properties of 4,5-deoxymaytansinoids,”Chem. Pharm. Bull, 1984, 32:(6), pp. 2194-2199.
Akiyoshi Kawai, et al., “Chemical Modification of Ansamitocins. III. Synthesis and Biological Effects of 3-Acyl Esters of Maytansinol,”Chem. Pharm. Bull, 1984, 32:(9), pp. 3441-3451.
Guenter Adam, “Biologically Active Natural Products as Synthetic Models in Active Substance Development,”Z. Chem., 1981, 21:(8), pp. 273-281.
Masayuki Shimagaki, “2-Halovinyl Aryl Sulfones: New Coupling Reagents for Caboxamide Formation,”Phosphorus Sulfur, 1983, 16:(1-2), pp. 45-48.
MetaChem Technologies, Inc., Liquid Chromatography, HPLC, IC, CE Column Guide, pp. 53-54 (2000/2001).
S. Morris Kupchan, et al., “Structural Requirements for Antileukemic Activity among the Naturally Occurring and Semisynthetic Maytansinoids,”Journal of Medicinal Chemistry, 1978, 21:(1), pp. 31-37.
Troels Skrydstrup, “The Opening of Trans-2-3-eopoxy-1-butanol Derivatives with Organometallic Reagents,”Tetrahedron Lett., 1990, 31:(49), pp. 7145-7148.
Xuegin Gu, “Studies on the Total Syntheses of Maytansinoids. (III). Synthesis of C5-N Fragment,”Sci. Sin., Ser. B (Engl. Ed.), 1998, 31:(11), pp. 1333-1341.
International Search Report dated Jun. 21, 2006.
Byng Graham S.
Kuo Cynthia
Widdison Wayne C.
Immunogen Inc.
Lilling Herbert J.
Sughrue & Mion, PLLC
LandOfFree
Methods for the production of ansamitocins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the production of ansamitocins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the production of ansamitocins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4019745